Chile and Brazil strengthen biotech and trade ties:
This article was originally published in Clinica
Chile and Brazil have signed a series of bilateral accords in a range of areas including health technology and trade. Biotechnology and genomics are among the areas of common interest in medical research; the two countries plan to set up new projects in these areas. The Chilean and Brazilian presidents, Ricardo Lagos and Fernando Henrique Cardoso, met last week in Arica, northern Chile, to also sign commercial agreements that seek to improve the flow of trade between the two countries, such as by reducing import/export tariffs. Other technical co-operation agreements involve joint investments in Brazilian small and medium-sized companies, reports the state news agency Agencia Brasil.
You may also be interested in...
EU Regulatory Round-Up, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.